Raghav, K. P. S., Guthrie, K. A., Tan, B., Denlinger, C. S., Fakih, M., Overman, M. J., Dasari, N. A., Corum, L. R., Hicks, L. G., Patel, M. S., Esparaz, B. T., Kazmi, S. M., Alluri, N., Colby, S., Gholami, S., Gold, P. J., Chiorean, E. G., Kopetz, S., Hochster, H. S., Philip, P. A. (2025). Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco-24-01710